Skip to main content
. Author manuscript; available in PMC: 2018 Dec 4.
Published in final edited form as: Vaccine. 2017 Oct 19;35(48 Pt B):6664–6671. doi: 10.1016/j.vaccine.2017.10.020

Figure 1. (a-d) Participant solicited symptoms and fever on vaccination day (day 0) the next day (day1) and (days 0 or 1) following inactivated influenza vaccine (IIV) according to treatment group.

Figure 1

.